Itraconazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Itraconazole and local guidelines before prescribing.
Mechanism
Triazole antifungal inhibiting ergosterol synthesis.
Uses
Aspergillosis, histoplasmosis, nail and skin fungal infection.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, rash, heart failure exacerbation, hepatotoxicity, QT prolongation.
Interactions
Potent CYP3A4 inhibitor; PPIs reduce absorption of capsules.
Contraindications and cautions
Heart failure, QT prolongation
Monitoring
LFT, ECG, levels
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Avoid in severe liver disease
Overdose and reversal
Supportive; not dialysable
Special advice
Take capsules with food and acid; avoid in heart failure; monitor LFT.
More from the textbook: uses, cautions and other points
- Interactions - CYP3A4 inhibitors ( clarithromycin , erythromycin, itraconazole, grapefruit juice with simvastatin), amiodarone and diltiazem (simvastatin dose limits), fibrates (gemfibrozil - avoid).
Cardiology: Anatomy Physiology and Pharmacology - Antifungals - voriconazole (aspergillosis - visual disturbance, photosensitivity, skin cancer risk, many interactions); itraconazole (ABPA, chronic aspergillosis).
Respiratory: Anatomy, Physiology and Pharmacology - Itraconazole (antifungal) to reduce the fungal load and steroid needs - check levels and watch for interactions (including steroid interactions causing Cushing's).
Respiratory: Airways Disease - Itraconazole | ABPA; check levels and interactions (including with inhaled budesonide - risk of Cushing's).
Respiratory: Airways Disease - Long courses of oral antifungals (itraconazole or voriconazole) for at least 6 months.
Respiratory: Infections - Itraconazole / voriconazole | Chronic pulmonary aspergillosis (and ABPA); voriconazole for invasive aspergillosis. Level monitoring; many interactions; voriconazole causes visual disturbance and photosensitivity.
Respiratory: Infections
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Airways Disease (3 mentions)
- Respiratory: Infections (2 mentions)
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Endocrinology: Adrenal Disease (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Neurology: Neuromuscular disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Dermatology: Skin infections and infestations (6 mentions)
- ID: How Infection Happens (1 mention)
- ID: Viral, fungal and parasitic infections (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Clinical Immunology: Primary immunodeficiency (3 mentions)
- Integrated respiratory chapter (5 mentions)
- Microbiology: Fungi, parasites and travel-related infection (2 mentions)